How many insider trades does FilingIQ track for ABEO?

FilingIQ tracks 278 Form 4 insider transactions for ABEO (ABEONA THERAPEUTICS INC.), covering filings from Jan 23, 2012 onwards. 4 of those were filed in the last 90 days.

Are ABEO insiders net buyers or net sellers?

Across the full Form 4 history for ABEO, 19 transactions (7%) were open-market purchases and 90 (32%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ABEO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ABEO in?

ABEONA THERAPEUTICS INC. (ABEO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $280.98M.

ABEO insider trading

NasdaqCM Healthcare

ABEONA THERAPEUTICS INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

278

Last 90 days

Buys / sells

7% / 32%

Market cap

$280.98M

About ABEONA THERAPEUTICS INC.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Company website: www.abeonatherapeutics.com

ABEO insider activity at a glance

FilingIQ has scored 278 insider transactions for ABEO since Jan 23, 2012. The most recent filing in our index is dated May 11, 2026.

Across the full history, 19 open-market purchases and 90 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ABEO insider trades is 55.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ABEO trades on FilingIQ Raw filings on SEC EDGAR

Latest ABEO Form 4 filings

Seshadri Vishwas Chief Executive Officer

S Jan 22, 2026

Seshadri Vishwas Chief Executive Officer

S Jul 9, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding ABEO

Nantahala Capital Management, LLC

$14.71M · 0.9% of AUM

Frequently asked

How many insider trades does FilingIQ track for ABEO?: FilingIQ tracks 278 Form 4 insider transactions for ABEO (ABEONA THERAPEUTICS INC.), covering filings from Jan 23, 2012 onwards. 4 of those were filed in the last 90 days.
Are ABEO insiders net buyers or net sellers?: Across the full Form 4 history for ABEO, 19 transactions (7%) were open-market purchases and 90 (32%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ABEO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ABEO in?: ABEONA THERAPEUTICS INC. (ABEO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $280.98M.

Methodology & sources

Every ABEO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.